Prudenia Sciences
Business Intelligence (BI) Software · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Cambridge, Massachusetts, 02142, United ...Website
prudentiasciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Prudenia Sciences
Led by CEO Sadiqa Mahmood, Prudentia Sciences provides an AI-native platform that enables pharma companies, biotechs, and financial institutions to evaluate breakthrough medicines with unprecedented speed and rigor. By synthesizing complex clinical signals into actionable insights, it accelerates deal throughput and provides strategic leverage for acquisition, licensing, or investment decisions made by business development, investment, and diligence teams.Explore more
Prudenia Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Prudenia Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Prudenia Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Prudenia Sciences is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Prudenia Sciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Prudenia Sciences had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Prudenia Sciences
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Prudenia Sciences launches new products
Funding: Get notified immidiatlly once Prudenia Sciences has new funding data
Earning: See what the market has to say on Prudenia Sciences recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Prudenia Sciences as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Prudenia Sciences is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Prudenia Sciences is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Prudenia Sciences.
Prudenia Sciences financials insights
Gather financial insights about Prudenia Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$7M
2026
Series A
$20M
Prudenia Sciences Tech Stack
A closer look at the technologies used by Prudenia Sciences
Most Recent Scoops
Hiring Plans
Prudenia Sciences has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Technologies mentioned include: Amazon AWS, LangChain, React , Docker, NoSQL, Snowflake, and GraphQL. Areas of expertise include: Use Case Analysis, Pre-Clinical Development, Pharming, Toxicology, Business Development, Decision Support Tools, and Strategic Positioning.
Hiring Plans
Open Position
Funding
Funding
Hiring Plans
Prudenia Sciences has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Technologies mentioned include: NoSQL, Snowflake, GraphQL, Python, LangChain, React , and Docker.
Hiring Plans
Hiring Plans
Hiring Plans
Prudenia Sciences News & Media
Read more news
Top Business Intelligence (BI) Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Prudenia Sciences
Sign Up For FreeTo access detailed company insights
Led by CEO Sadiqa Mahmood, Prudentia Sciences provides an AI-native platform that enables pharma companies, biotechs, and financial institutions to evaluate breakthrough medicines with unprecedented speed and rigor. By synthesizing complex clinical signals into actionable insights, it accelerates deal throughput and provides strategic leverage for... Read More
